Ana Cristina Bairrada Fortuna

Algoritmi | User | Ana Cristina Bairrada Fortuna

At LASI

Member of the CIBIT R&D Unit

Academic Degree

Current Position

Personal Webpage

Personal Email

anacfortuna@gmail.com

Orcid

0000-0001-6981-6639

Researcher ID

FCT Public Key

Ciência ID

E510-8BF0-1756

Google Scholar

About Me

Ana Fortuna is graduated in Pharmaceutical Sciences since 2007 and obtained her PhD degree in Pharmaceutical Sciences, specialty of Pharmacology, in 2011 at the Faculty of Pharmacy of University of Coimbra (FFUC). Ana Fortuna holds European Certified Pharmacologist (EuCP) since 2021 and she received 11 national/international awards, including the World's Top 2% Scientists of 2022. She is an Assistant Professor at FFUC since 2011 in the area of Pharmacology and Pharmaceutical Care and an integrated researcher at the Coimbra Institute for Biomedical Imaging and Translational Research of University of Coimbra (CIBIT). She is currently the supervisor of 5 PhD students (1 in collaboration with the pharmaceutical industry, 2 with University of Barcelona and 1 with CHUC), co-supervisor of 2 PhD students and supervisor of 3 Master students in Applied Pharmacology. She has already successfully supervised 2 PhD students, 20 master's students and 29 integrated master's degree students. With a SCOPUS H-INDEX of 28 and 2548 total CITATIONS (Google Scholar: H-index 32 and 3542 citations), Ana Fortuna published 97 articles in international journals; among them, she was the first/last author or the corresponding author of 40 manuscripts. She is also the author of 1 Editorial, 11 book chapters, and more than 100 oral/poster communications at scientific meetings and 3 international patents. She is the principal investigator of the project CENTRO-01-0145-FEDER-030752 (2018-2022) and SustaINsafety (financed by INOVC+), both aiming at developing Nose-to-Brain systems for the treatment of drug-resistant depression. In parallel, Ana Fortuna integrates 7 more funded projects. Her main research areas include: interaction between drugs and efflux transporters, in vitro/in vivo pharmacokinetics and pharmacodynamics of new drugs for depression, epilepsy and Alzheimer´s disease, as well as development/validation of bioanalytical techniques that are employed on drug pharmacokinetics monitoring throughout a personalized pharmacotherapy. These researches allowed Ana Fortuna to establish different collaborations, namely with pharmaceutical industries (Laboratórios BIAL, Hovione, Aptar Pharma), Centro Hospitalar e Universitário de Coimbra (CHUC, EPE, Coimbra, Portugal) and other public national (Universidade da Beira Interior, Universidade do Porto, Universidade de Aveiro and Universidade do Algarve). At the international level, she collaborates with recognized researchers from Spain (Univ. of Barcelona and Univ. of Salamanca), Italy (University of Parma), Germany (Biberach University of Applied Sciences) and Brazil (Universidade Federal de São Paulo).

Publications (156)

Precision Meets Affordability: A Highly Sensitive HPLC-FLD Technique for Accurate Pitavastatin Quantification in Human Plasma

2023 | conference-paper